Sensitivity of the N-methyl-D-aspartate receptor channel to butyrophenones is dependent on the ε2 subunit

Neuropharmacology

Volumn 37, Issue 6, 1998, Pages 709-717

  Yamakura, Tomohiro ^a   Sakimura, Kenji ^b   Mishina, Masayoshi ^c   Shimoji, Koki ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

2 subunit; Butyrophenone; Haloperidol; Mg2+ block; NMDA receptor channel; Site directed mutagenesis

Indexed keywords

ASPARAGINE; BUTYROPHENONE DERIVATIVE; DROPERIDOL; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HALOPERIDOL; MAGNESIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBUNIT; SPIPERONE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL MEMBRANE POTENTIAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; NONHUMAN; OOCYTE; PRIORITY JOURNAL; XENOPUS;

AMINO ACID SUBSTITUTION; ANIMALS; ANTIPSYCHOTIC AGENTS; BUTYROPHENONES; DROPERIDOL; HALOPERIDOL; MAGNESIUM; MUTAGENESIS, SITE-DIRECTED; PATCH-CLAMP TECHNIQUES; RECEPTORS, N-METHYL-D-ASPARTATE; SPIPERONE; XENOPUS LAEVIS;

EID: 0031811331     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00047-1     Document Type: Article

References (33)

1. Banerjee S.P., Zuck L.G., Yablonsky-Alter E., Lidsky T.I. Glutamate agonist activity: implications for antipsychotic drug action and schizophrenia. NeuroReport. 6:1995;2500-2504.
2. Bowen W.D., Moses E.L., Tolentino P.J., Walker J.M. Metabolites of haloperidol display preferential activity at σ receptors compared to dopamine D-2 receptors. Eur. J. Pharmacol. 177:1990;111-118.
3. DeCoster M.A., Klette K.L., Knight E.S., Tortella F.C. σ receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures. Brain Res. 671:1995;45-53.
4. Fletcher E.J., MacDonald J.F. Haloperidol interacts with the strychnine-insensitive glycine site at the NMDA receptor in cultured mouse hippocampal neurones. Eur. J. Pharmacol. 235:1993;291-295.
5. 2+ mobilization by N-methyl-D-aspartate in primary culture of rat frontal cortical neurons. J. Pharmacol. Exp. Ther. 275:1995;207-214.
6. Headley P. M., Parsons C.G., West D.C. The role of N-methylaspartate receptors in mediating responses of rat and cat spinal neurones to defined sensory stimuli. J. Physiol. 385:1987;169-188.
7. Hollmann M., Heinemann S. Cloned glutamate receptors. Annu. Rev. Neurosci. 17:1994;31-108.
8. Honey C.R., Miljkovic Z., MacDonald J.F. Ketamine and phencyclidine cause a voltage-dependent block of responses to L-aspartic acid. Neurosci. Lett. 61:1985;135-139.
9. Huettner J.E., Bean B.P. Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: Selective binding to open channels. Proc. Natl. Acad. Sci. USA. 85:1988;1307-1311.
10. Ikeda K., Nagasawa M., Mori H. et al. Cloning and expression of the ε4 subunit of the NMDA receptor channel. FEBS Lett. 313:1992;34-38.
11. Ilyin V.I., Whittemore E.R., Guastella J., Weber E., Woodward R.M. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol. Mol. Pharmacol. 50:1996;1541-1550.
12. Korpi E.R., Kleinman J.E., Costakos D.T., Linnoila M., Wyatt R.J. Reduced haloperidol in the post-mortem brains of haloperidol-treated patients. Psychiatry Res. 11:1984;259-269.
13. Kutsuwada T., Kashiwabuchi N., Mori H. et al. Molecular diversity of the NMDA receptor channel. Nature. 358:1992;36-41.
14. 3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. J. Pharmacol. Exp. Ther. 238:1986;739-748.
15. Leonard J.P., Kelso S.R. Apparent desensitization of NMDA responses in Xenopus oocytes involves calcium-dependent chloride current. Neuron. 4:1990;53-60.
16. Lockhart B.P., Soulard P., Benicourt C., Privat A., Junien J.-L. Distinct neuroprotective profiles for σ ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies. Brain Res. 675:1995;110-120.
17. Malouf A.T., Swearengen E., Chavkin C. Comparison of the actions of phencyclidine and sigma ligands on CA1 hippocampal pyramidal neurons in the rat. Neuropharmacology. 27:1988;1161-1170.
18. 3 dorsal hippocampus by sigma ligands. J. Pharmacol. Exp. Ther. 261:1992;123-130.
19. Monnet F.P., Debonnel G., Junien J.-L., De Montigny C. N-Methyl-D-aspartate-induced neuronal activation is selectively modulated by σ receptors. Eur. J. Pharmacol. 179:1990;441-445.
20. 2+-block site of the NMDA receptor channel. Nature. 358:1992;673-675.
21. Mori H., Mishina M. Structure and function of the NMDA receptor channel. Neuropharmacology. 34:1995;1219-1237.
22. Mori H., Yamakura T., Masaki H., Mishina M. Involvement of the carboxyl-terminal region in modulation by TPA of the NMDA receptor channel. NeuroReport. 4:1993;519-522.
23. Parsons C.G., Gibbens H., Magnago T.S.I., Headley P.M. At which sigma site are the spinal actions of ketamine mediated? Neurosci. Lett. 85:1988;322-328.
24. 3H]1,3-Di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by σ ligands. Mol. Pharmacol. 39:1991;222-232.
25. Sakimura K., Bujo H., Kushiya E. et al. Functional expression from cloned cDNAs of glutamate receptor species responsive to kainate and quisqualate. FEBS Lett. 272:1990;73-80.
26. 4. Neuropsychopharmacology. 7:1992;261-284.
27. 3H]haloperidol binding in guinea pig brain membranes. Proc. Natl. Acad. Sci. USA. 81:1984;5618-5621.
28. Watanabe M., Mishina M., Inoue Y. Distinct spatiotemporal distributions of the N-methyl-D-aspartate receptor channel subunit mRNAs in the mouse cervical cord. J. Comp. Neurol. 345:1994;314-319.
29. Wurzburger R.J., Miller R.L., Marcum E.A., Colburn W.A., Spector S. A new radioimmunoassay for haloperidol: direct measurement of serum and striatal concentrations. J. Pharmacol. Exp. Ther. 217:1981;757-763.
30. Yamakura T., Mori H., Masaki H., Shimoji K., Mishina M. Different sensitivities of NMDA receptor channel subtypes to non-competitive antagonists. NeuroReport. 4:1993;687-690.
31. Yamakura T., Mori H., Shimoji K., Mishina M. Phosphorylation of the carboxyl-terminal domain of the ζ1 subunit is not responsible for potentiation by TPA of the NMDA receptor channel. Biochem. Biophys. Res. Commun. 196:1993;1537-1544.
32. Yamamoto H., Yamamoto T., Sagi N. et al. Sigma ligands indirectly modulate the NMDA receptor-ion channel complex on intact neuronal cells via σ1 site. J. Neurosci. 15:1995;731-736.
33. Yamazaki M., Mori H., Araki K., Mori K.J., Mishina M. Cloning, expression and modulation of a mouse NMDA receptor subunit. FEBS Lett. 300:1992;39-45.